Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Ma's clinical and research interests are focused on chronic lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHL). Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphomas. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.